Pitt team IDs two new, very large classes of RNAs linked to cancer biomarker
2015-05-26
(Press-News.org) PITTSBURGH, May 26, 2015 - Researchers at the University of Pittsburgh School of Medicine have identified two new classes of RNAs that are closely associated with a protein known to be a prognostic biomarker for breast cancer and could play a role in progression of prostate cancer. Their findings were published in the June issue of the scientific journal RNA.
Levels of human Y-box binding protein 1 (YB-1), which is involved in many cellular functions, have been shown to correlate with drug resistance and poor patient outcomes in a variety of cancers. The observation that this cancer biomarker is tightly linked to a surprisingly large and diverse class of RNAs, and the known associations of some of these RNAs to cancer opens an opportunity to discover a potentially very important pathway in human biology and cancer, said senior investigator Bino John, Ph.D., adjunct professor, Pitt School of Medicine, where the research was conducted.
Intriguingly, one of the abundant RNAs that the team discovered was found to originate from the widely known DNA region of the Dicer1 gene and was determined to control multiple genes involved in cancer progression.
"Many small RNAs known as microRNAs already have been shown to correlate with different grades of prostate cancer and could potentially serve as biomarkers for diagnosis and treatment," Dr. John said. "We did this study after computer models led us to hypothesize that there was a connection between YB-1 and microRNAs. What started out as a curiosity-driven experiment ended up being an exhilarating treasure hunt over four years, culminating in the discovery of two big molecular finds from human cells."
The Pitt scientists discovered that YB-1 associated with many microRNAs, and were surprised by the realization that YB-1 associated with thousands of RNAs that were never before known. The team grouped the RNAs into what they called YB-1 associated short non-coding RNAs, or shyRNAs, and their smaller, processed counterparts, dubbed YB-1 associated small RNAs (smyRNAs).
"We conducted functional assays on one of these RNAs, and found that it had the ability to suppress cancer cell growth when it interacted with YB-1," said co-senior author Donald B. DeFranco, Ph.D., professor of pharmacology and chemical biology, Pitt School of Medicine. "More work must be done to determine how these shyRNAs interact to influence cancer progression and perhaps influence other diseases."
INFORMATION:
The team included Teresa T. Liu, Ph.D., Gustavo Arango-Argoty, Zhihua Li, Ph.D., Yuefeng Lin, Sang Woo Kim, Ph.D., and A. Paula Monaghan, Ph.D., all of Pitt at the time of the study; Anne Dueck, Ph.D., and Gunter Meister, Ph.D., of the University of Regensburg; and Fatih Ozsolak, Ph.D., of Helicos Biosciences.
The research was supported by the Mathers Foundation; National Institutes of Health grant GM079756; American Cancer Society; Deutsche Forschungsgemeinschaft; the European Research Council; and the Bavarian Genome Research Network.
About the University of Pittsburgh School of Medicine
As one of the nation's leading academic centers for biomedical research, the University of Pittsburgh School of Medicine integrates advanced technology with basic science across a broad range of disciplines in a continuous quest to harness the power of new knowledge and improve the human condition. Driven mainly by the School of Medicine and its affiliates, Pitt has ranked among the top 10 recipients of funding from the National Institutes of Health since 1998. In rankings recently released by the National Science Foundation, Pitt ranked fifth among all American universities in total federal science and engineering research and development support.
Likewise, the School of Medicine is equally committed to advancing the quality and strength of its medical and graduate education programs, for which it is recognized as an innovative leader, and to training highly skilled, compassionate clinicians and creative scientists well-equipped to engage in world-class research. The School of Medicine is the academic partner of UPMC, which has collaborated with the University to raise the standard of medical excellence in Pittsburgh and to position health care as a driving force behind the region's economy. For more information about the School of Medicine, see http://www.medschool.pitt.edu.
http://www.upmc.com/media
Contact: Anita Srikameswaran
Phone: 412-720-2058
E-mail: SrikamAV@upmc.edu
Contact: Allison Hydzik
Phone: 412-647-9975
E-mail: HydzikAM@upmc.edu
ELSE PRESS RELEASES FROM THIS DATE:
2015-05-26
CINCINNATI - Maxing out the inherently stressed nature of treatment-resistant breast cancer cells thwarts their adaptive ability to evolve genetic workarounds to treatment, a new study suggests.
Scientists from Cincinnati Children's Hospital Medical Center report their results May 26 in Science Signaling.
"We present an alternative generic strategy for cancer treatment, which is removing cancer cells' defenses against their own intrinsic stress," said Kakajan Komurov, PhD, lead author and a researcher at the Cancer and Blood Disease Institute at Cincinnati Children's. ...
2015-05-26
The importance of the umbilical cord not only for the fetus but for newborn infants too was shown by Swedish researchers several years ago, in a study that received great international acclaim. In a follow-up study in the journal JAMA Pediatrics they have now been able to show an association between delayed cord clamping (DCC) and children's fine motor skills at the age of four years, especially in boys.
Several years ago, in a clinical study comprising 400 newborns, Dr. Ola Andersson and colleagues demonstrated that the risk of iron deficiency at the age of four months ...
2015-05-26
Racial stereotypes and expectations can impact the way we communicate and understand others, according to UBC research.
The new study, published in the Journal of the Acoustical Society of America, highlights how non-verbal "social cues" - such as photographs of Chinese Canadians - can affect how we comprehend speech.
"This research brings to light our internal biases, and the role of experience and stereotypes, in how we listen to and hear each other," says Molly Babel, the paper's lead author and an assistant professor with UBC's Department of Linguistics.
One of ...
2015-05-26
PITTSBURGH, May 26, 2015 - Researchers at the University of Pittsburgh School of Medicine have identified two new classes of RNAs that are closely associated with a protein known to be a prognostic biomarker for breast cancer and could play a role in progression of prostate cancer. Their findings were published in the June issue of the scientific journal RNA.
Levels of human Y-box binding protein 1 (YB-1), which is involved in many cellular functions, have been shown to correlate with drug resistance and poor patient outcomes in a variety of cancers. The observation that ...
2015-05-26
If you want to strike up a new relationship, simply smile. It works because people are much more attuned to positive emotions when forming new bonds than they are to negative ones such as anger, contempt or sadness. Don't try to fake it, however, because people can recognize a sincere smile a mile away. This is according to a study led by Belinda Campos of the University of California, Irvine, in the US that sheds light on how relationships are formed and maintained. The findings are published in Springer's journal Motivation and Emotion.
Campos' team conducted two studies ...
2015-05-26
Infants are capable of understanding relations like "same" and "different"
Analogical learning processes are present in prelinguistic human infants
EVANSTON, Ill. --- Two pennies can be considered the same -- both are pennies, just as two elephants can be considered the same, as both are elephants. Despite the vast difference between pennies and elephants, we easily notice the common relation of sameness that holds for both pairs.
Analogical ability -- the ability to see common relations between objects, events or ideas -- is a key skill that underlies human intelligence ...
2015-05-26
Quantum computers are largely theoretical devices that could perform some computations exponentially faster than conventional computers can. Crucial to most designs for quantum computers is quantum error correction, which helps preserve the fragile quantum states on which quantum computation depends.
The ideal quantum error correction code would correct any errors in quantum data, and it would require measurement of only a few quantum bits, or qubits, at a time. But until now, codes that could make do with limited measurements could correct only a limited number of errors ...
2015-05-26
We live in fear of 'superbugs': infectious bacteria that don't respond to treatment by antibiotics, and can turn a routine hospital stay into a nightmare. A 2015 Health Canada report estimates that superbugs have already cost Canadians $1 billion, and are a "serious and growing issue." Each year two million people in the U.S. contract antibiotic-resistant infections, and at least 23,000 people die as a direct result.
But tests for antibiotic resistance can take up to three days to come back from the lab, hindering doctors' ability to treat bacterial infections quickly. ...
2015-05-26
Chronic pain affects hundreds of millions of people worldwide and is a major cause of disability, causing more disability than cancer and heart disease. Canadian researchers, including Michael Salter at SickKids are shedding light on the molecular dynamics of chronic pain. They have uncovered a critical role for a class of cells present in the brain and spinal cord, called microglia, in pain. They have found microglia-to-neuron-signaling to be crucial in the development of pain hypersensitivity after injury, but also for one of the paradoxical effects morphine and other ...
2015-05-26
Promising results from a trial of a new stem-cell based therapy for a rare and debilitating skin condition have been published in the Journal of Investigative Dermatology. The therapy, involving infusions of stem cells, was found to provide pain relief and to reduce the severity of this skin condition for which no cure currently exists.
The clinical trial, led by King's College London in collaboration with Great Ormond Street Hospital (GOSH), recruited 10 children with recessive dystrophic epidermolysis bullosa (RDEB).
RDEB is a painful skin disease in which very minor ...
LAST 30 PRESS RELEASES:
[Press-News.org] Pitt team IDs two new, very large classes of RNAs linked to cancer biomarker
